Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
7.95
+0.14 (1.79%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sera Prognostics Revenue
Sera Prognostics had revenue of $24.00K in the quarter ending June 30, 2024, a decrease of -80.49%. This brings the company's revenue in the last twelve months to $107.00K, down -71.47% year-over-year. In the year 2023, Sera Prognostics had annual revenue of $306.00K with 14.18% growth.
Revenue (ttm)
$107.00K
Revenue Growth
-71.47%
P/S Ratio
n/a
Revenue / Employee
$1,877
Employees
57
Market Cap
265.28M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 306.00K | 38.00K | 14.18% |
Dec 31, 2022 | 268.00K | 186.00K | 226.83% |
Dec 31, 2021 | 82.00K | 57.00K | 228.00% |
Dec 31, 2020 | 25.00K | -11.00K | -30.56% |
Dec 31, 2019 | 36.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accolade | 441.03M |
Amarin Corporation | 241.02M |
Zynex | 193.67M |
Heron Therapeutics | 136.36M |
Poseida Therapeutics | 88.46M |
Artiva Biotherapeutics | 29.26M |
TScan Therapeutics | 12.20M |
Immutep | 2.56M |
SERA News
- 3 days ago - Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
- 7 days ago - Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024 - PRNewsWire
- 2 months ago - Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 3 months ago - Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 - PRNewsWire
- 3 months ago - SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS - PRNewsWire
- 3 months ago - Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 - PRNewsWire
- 4 months ago - Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial - PRNewsWire